Cardiotoxicity among socioeconomically marginalized breast cancer patients.

ABSTRACT:

Purpose

Evidence of cardiotoxicity risk related to anthracycline or trastuzumab exposure is largely derived from breast cancer cohorts that under-represent socioeconomically marginalized women, who may be at increased risk of cardiotoxicity because of high prevalence of cardiovascular disease risk factors. Therefore, we aimed to estimate cardiotoxicity risk among socioeconomically marginalized breast cancer patients treated with anthracyclines or trastuzumab and describe clinical consequences of cardiotoxicity.

Methods

We linked electronic health records with institutional registry data from a Comprehensive Community Cancer Program within a safety-net health system. Eligible patients were adult females, diagnosed with first primary invasive breast cancer between 2013 and 201

SUBMITTER: Lu Y 

PROVIDER: S-EPMC9464741 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature